LHC Group, Inc. (LHCG) Receives Consensus Rating of “Buy” from Analysts
Shares of LHC Group, Inc. (NASDAQ:LHCG) have been given an average rating of “Buy” by the thirteen analysts that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and nine have given a buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $76.89.
Several research firms have recently issued reports on LHCG. Robert W. Baird reissued a “hold” rating and set a $63.00 target price on shares of LHC Group in a report on Tuesday, September 12th. Zacks Investment Research lowered LHC Group from a “buy” rating to a “hold” rating in a research note on Wednesday, October 4th. SunTrust Banks reaffirmed a “buy” rating and issued a $75.00 price objective on shares of LHC Group in a research note on Friday, November 3rd. Jefferies Group raised their price objective on LHC Group from $68.00 to $83.00 and gave the company a “buy” rating in a research note on Tuesday, November 7th. They noted that the move was a valuation call. Finally, Royal Bank of Canada raised their price objective on LHC Group from $70.00 to $81.00 and gave the company an “outperform” rating in a research note on Tuesday, November 7th.
Institutional investors and hedge funds have recently modified their holdings of the company. Federated Investors Inc. PA raised its position in shares of LHC Group by 4.2% during the second quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock worth $110,000 after acquiring an additional 66 shares during the last quarter. Acrospire Investment Management LLC raised its position in shares of LHC Group by 30.8% during the second quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock worth $115,000 after acquiring an additional 400 shares during the last quarter. Cubist Systematic Strategies LLC raised its position in shares of LHC Group by 758.0% during the second quarter. Cubist Systematic Strategies LLC now owns 1,716 shares of the health services provider’s stock worth $116,000 after acquiring an additional 1,516 shares during the last quarter. SG Americas Securities LLC bought a new position in shares of LHC Group during the third quarter worth about $163,000. Finally, ETRADE Capital Management LLC bought a new position in shares of LHC Group during the second quarter worth about $219,000. Institutional investors own 85.41% of the company’s stock.
LHC Group (NASDAQ:LHCG) last issued its quarterly earnings data on Monday, November 6th. The health services provider reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.60 by $0.04. LHC Group had a return on equity of 9.52% and a net margin of 4.09%. The firm had revenue of $272.90 million for the quarter, compared to analyst estimates of $265.35 million. During the same period in the prior year, the firm posted $0.54 EPS. The company’s revenue for the quarter was up 18.2% on a year-over-year basis. research analysts expect that LHC Group will post 2.4 EPS for the current year.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.